FDA panel OKs Thoratec heart-pump device

An FDA panel unanimously voted to support the approval of Thoratec Corp.'s HeartMate II, a heart-pump device intended for heart-failure patients awaiting transplants, despite a failure to reach its preset goal. The panel said the agency must require a post-market study, and the device's warning label must state the product should not be given to patients who cannot tolerate anticlotting drugs.

View Full Article in:

Forbes · Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Counsel – Regulatory Affairs
RAI Services Company
Winston-Salem, NC
Senior Counsel Commercial
RAI Services Company
Winston Salem, NC
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL